Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Effect of Terlipressin on Recovery of Liver Function After Hepatectomy: a Multicenter Randomized Controlled Study

NCT04221672 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT04221672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04221672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Effect of Terlipressin on Recovery of Liver Function After Hepatectomy: a Multicenter Randomized Controlled Study
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
November 7, 2019
Completion date
December 30, 2020
Enrollment
86 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, ascites hepatic, liver failure, terlipressin adverse reaction